We serve Chemical Name:3-phenyl-1H-pyridin-2-one CAS:24228-13-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-phenyl-1H-pyridin-2-one
CAS.NO:24228-13-5
Synonyms:3-phenyl-2-pyridone;3-phenylpyridin-2-one;3-Phenylpyridin-2-ol;2-HYDROXY-3-PHENYLPYRIDINE;3-Phenyl-2-hydroxypyridine
Molecular Formula:C11H9NO
Molecular Weight:171.19500
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:417.1ºC at 760mmHg
Density:1.158g/cm3
Index of Refraction:1.594
PSA:33.12000
Exact Mass:171.06800
LogP:2.45420
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-phenyl-2-pyridone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Phenyl-2-hydroxypyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-phenylpyridin-2-one Use and application,3-Phenylpyridin-2-ol technical grade,usp/ep/jp grade.
Related News: The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 3-phenyl-1H-pyridin-2-one manufacturer The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful. 3-phenyl-1H-pyridin-2-one supplier Taiwan previously participated as an observer at the World Health Assembly, the W.H.O.��s governing body. 3-phenyl-1H-pyridin-2-one vendor The FDA issued a stark warning to the public urging them to stop using rapid COVID-19 antigen tests developed by Innova Medical Group, the company previously tapped by the U.K. government for hundreds of millions of kits to help regularly screen the country’s population. 3-phenyl-1H-pyridin-2-one factory The results of analysis perfectly align with the tau hypothesis — simply put, if the patient is tau biomarker positive, then tau pathology is responsible for his/her cognitive decline, and halting tau pathology should slow or halt progression,” Novak said. “If the patient is negative for markers of tau pathology, then this patient’s impairment is mainly due to other pathologies, and treating tau pathology in this patient won’t be meaningful.
